Form 4: NeueHealth Director Acquires Warrants Following Agreement

Paul Edward Walker, a director at NeueHealth, acquired warrants to purchase common stock following a warrantholders agreement.

Summary

• On April 8, 2024, Paul Edward Walker, a director of NeueHealth, Inc., was granted warrants to purchase common stock.
• The warrants are associated with a Warrantholders Agreement dated April 8, 2024, and an amended Credit Agreement.
• The warrants are exercisable after the closing date, which is the first business day following the conclusion of the 10 calendar day period after the distribution of the letter required to be mailed by the Issuer to its shareholders pursuant to Section 312.05 of the NYSE Listed Company Manual, and prior to the close of business on the fifth anniversary of the Closing Date.
• Walker indirectly acquired warrants for 123,729 shares through NEA 16, 123,729 shares through NEA 17, and 371,187 shares through NEA 18 VGE.
• Walker disclaims beneficial ownership of the securities held by NEA 16, NEA 17, and NEA 18 VGE, except to the extent of his pecuniary interest.
• Zachary Bambach, acting as attorney-in-fact, signed the Form 4 on April 10, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing warrant acquisitions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Future Outlook

The warrants are exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.

Industry Context

This filing reflects insider activity related to warrant acquisitions, which is a common practice in corporate finance and investment agreements. It indicates potential future equity ownership changes.

Stakeholder Impact

• The warrant issuance could potentially dilute existing shareholders if the warrants are exercised in the future.

Key Dates